Out-licensing: Hospital And Surgery

Latest: Watch here for details of new products and services.

About Us: Innovaro Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Pay-per-Click New!; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Innovaro Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..10 of 72 - per page Next page
Order by

Hyalobarrier®

Hyaluronan based gel for prevention and reduction of adhesion formation in the abdominal pelvic area More

Cellophil(TM) Biomedical Polymer - New and superior biomedical polymers for a new standard in the medical device industry.

Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More

Collatamp® G US

Surgical implant for treatment and prevention of post-operative infections More

Hyalomatrix® PA

Hyaluronan based matrix to manage severe burns and full-thickness wounds More

Erythropoietin

rHu EPO More

Micro Fine, Dry Powder Pulmonary Drug Delivery Technology Suite

A Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More

CollaRx® & LiquiColl® Technologies

Collagen-based biodegradable matrices for localized drug delivery More

Pegylated Filgrastim

Peg GCSF More

Surgical Adhesion Barrier

Collagen-based adhesion barrier for the prevention of surgical adhesions More

Retinoid Acid Receptor Antagonists in Bone and Cartilage Repair

Identification and use of RAR antagonists to induce bone and cartilage formation More

Displaying 1..10 of 72 - per page Next page
Order by

Your selection

Therapeutic target: Hospital and Surgery del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Therapeutic target: Adhesion; Anesthesia; Bleeding; Cosmetic surgery; Dialysis; Disinfectant; Fibrosis; General surgery; Infection control; Infusion; Injection; Intravenous; Irrigation; Perfusion; Plasma expander; Plasma substitute; Surgery (other); Tissue grafting; Transplantation; Wound closure
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Innovaro Pharmalicensing current industry press releases.

Products:	Partnering Search	Pay-per-Click	Company Profiling	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us